Form 8-K - Current report:
SEC Accession No. 0001193125-25-032003
Filing Date
2025-02-21
Accepted
2025-02-21 16:15:44
Documents
13
Period of Report
2025-02-18
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K d812932d8k.htm   iXBRL 8-K 23531
  Complete submission text file 0001193125-25-032003.txt   144507

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vrca-20250218.xsd EX-101.SCH 2850
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE vrca-20250218_lab.xml EX-101.LAB 17994
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vrca-20250218_pre.xml EX-101.PRE 11261
15 EXTRACTED XBRL INSTANCE DOCUMENT d812932d8k_htm.xml XML 3618
Mailing Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380
Business Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380 484-453-3300
Verrica Pharmaceuticals Inc. (Filer) CIK: 0001660334 (see all company filings)

EIN.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38529 | Film No.: 25652095
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)